Innovative Radiotherapy Solutions MVision AI's development of responsible AI tools and guideline-based segmentation solutions positions it as a leader in automating and standardizing radiotherapy planning, appealing to hospitals and cancer treatment centers seeking cutting-edge, efficient treatment workflows.

Expanding Market Reach Recent partnerships, including a distribution agreement with Medron Medical Systems in Canada and installations across hospitals in Europe such as Slovakia, indicate ongoing expansion opportunities into international markets with high demand for advanced radiotherapy automation.

Recent Product Launches The launch of Contour+ and the comprehensive GBS™ solution highlight MVision AI's proactive growth strategy, opening sales avenues with healthcare providers seeking innovative tools to improve treatment speed, consistency, and patient outcomes.

Strong Growth Funding With over 5.9 million euros raised in post-seed financing from prominent venture firms, MVision AI is well-positioned to scale its sales efforts, develop new features, and penetrate larger healthcare markets globally.

Technology-Driven Approach Leveraging advanced deep learning models and a tech stack incorporating cloud and security tools, MVision AI appeals to tech-savvy hospitals and clinics aiming for high-quality, automated radiotherapy solutions that streamline workflows and reduce manual workload.